Indication: Adults with hypercholesterolemia and/or hypertriglyceridemia who are unsatisfactory with dietary therapy.

Indication: The following infectious diseases caused by Gram-positive bacteria: 1. Tonsillitis, suppurative otitis media, sinusitis, etc. 2. Acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc. 3. Skin and soft tissue infections: furuncle, sore, abscess, cellulitis, trauma, burns and surgical infection, etc. 4. Urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5. Others: myelitis, sepsis, peritonitis and oral infection, etc. Various infectious diseases caused by anaerobic bacteria: 1. Empyema, muscle abscess, anaerobic pneumonia. 2. Skin and soft tissue infection, sepsis. 3. Intraperitoneal infection: peritonitis, intraperitoneal abscess. 4. Female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess.

Indication: Suitable for primary hyperlipidemia.

Indication: Suitable for primary hyperlipidemia.

Indication: This product is used for cholesterol gallstone formation and bile-deficient steatorrhea. It can also be used to prevent drug-induced stone formation and treat steatorrhea (after ileal resection).

Indication: This product is used to treat hyperlipidemia in adults who have not responded well to dietary control therapy. Its triglyceride-lowering effect is more obvious than its cholesterol-lowering effect, and is effective for hyperlipoproteinemia of type III, IV, and V. However, this product cannot completely replace dietary control therapy and can only be used as an auxiliary treatment based on dietary control. In addition, clofibrate is currently used clinically for atherosclerosis and its secondary diseases, such as coronary artery disease, cerebrovascular disease, peripheral vascular disease, and arterial disease caused by diabetes.

Indication: Hyperlipidemia, its triglyceride-lowering effect is more obvious than its cholesterol-lowering effect. In view of the potential carcinogenicity of this product to humans, its use should be strictly limited to the specified range of indications, and the drug should be discontinued in time if the therapeutic effect is not obvious.

Indication: It is suitable for hyperlipidemia caused by various reasons, and is effective in lowering cholesterol and triglycerides. It can be used for both familial and non-familial hyperlipidemia. It can be used as a first-line lipid-lowering drug, and as an alternative drug when other lipid-lowering drugs fail. It is especially suitable for patients with hyperlipidemia and diabetes, because it can not only lower blood lipids but also improve glucose tolerance. While lowering lipids, the drug can significantly reduce the risk of atherosclerosis in patients.